162 related articles for article (PubMed ID: 33989916)
1. Advancements in folate receptor targeting for anti-cancer therapy: A small molecule-drug conjugate approach.
Rana A; Bhatnagar S
Bioorg Chem; 2021 Jul; 112():104946. PubMed ID: 33989916
[TBL] [Abstract][Full Text] [Related]
2. Small Molecule-Drug Conjugates: Opportunities for the Development of Targeted Anticancer Drugs.
Zhang J; Hu F; Aras O; Chai Y; An F
ChemMedChem; 2024 Jun; 19(11):e202300720. PubMed ID: 38396351
[TBL] [Abstract][Full Text] [Related]
3. Preparation of Ligand-Targeted Drug Conjugates for Cancer Therapy and Their Evaluation In Vitro.
Krishnan MA; Sengupta S; Chelvam V
Curr Protoc Chem Biol; 2018 Dec; 10(4):e50. PubMed ID: 30212603
[TBL] [Abstract][Full Text] [Related]
4. Chemical generation of small molecule-based bispecific antibody-drug conjugates for broadening the target scope.
Yamaguchi A; Anami Y; Ha SYY; Roeder TJ; Xiong W; Lee J; Ueno NT; Zhang N; An Z; Tsuchikama K
Bioorg Med Chem; 2021 Feb; 32():116013. PubMed ID: 33482584
[TBL] [Abstract][Full Text] [Related]
5. Folate-vinca alkaloid conjugates for cancer therapy: a structure-activity relationship.
Leamon CP; Vlahov IR; Reddy JA; Vetzel M; Santhapuram HK; You F; Bloomfield A; Dorton R; Nelson M; Kleindl P; Vaughn JF; Westrick E
Bioconjug Chem; 2014 Mar; 25(3):560-8. PubMed ID: 24564229
[TBL] [Abstract][Full Text] [Related]
6. Targeting the Folate Receptor: Improving Efficacy in Inorganic Medicinal Chemistry.
Carron PM; Crowley A; O'Shea D; McCann M; Howe O; Hunt M; Devereux M
Curr Med Chem; 2018; 25(23):2675-2708. PubMed ID: 29424300
[TBL] [Abstract][Full Text] [Related]
7. A branched small molecule-drug conjugate nanomedicine strategy for the targeted HCC chemotherapy.
Li SS; Zhang CM; Wu JD; Liu C; Liu ZP
Eur J Med Chem; 2022 Jan; 228():114037. PubMed ID: 34883290
[TBL] [Abstract][Full Text] [Related]
8. Regioselective synthesis of folate receptor-targeted agents derived from epothilone analogs and folic acid.
Vlahov IR; Vite GD; Kleindl PJ; Wang Y; Santhapuram HK; You F; Howard SJ; Kim SH; Lee FF; Leamon CP
Bioorg Med Chem Lett; 2010 Aug; 20(15):4578-81. PubMed ID: 20594844
[TBL] [Abstract][Full Text] [Related]
9. Small molecule- and peptide-drug conjugates addressing integrins: A story of targeted cancer treatment.
Paulus J; Sewald N
J Pept Sci; 2024 Jul; 30(7):e3561. PubMed ID: 38382900
[TBL] [Abstract][Full Text] [Related]
10. PSMA-targeted small-molecule docetaxel conjugate: Synthesis and preclinical evaluation.
Machulkin AE; Uspenskaya AA; Zyk NY; Nimenko EA; Ber AP; Petrov SA; Shafikov RR; Skvortsov DA; Smirnova GB; Borisova YA; Pokrovsky VS; Kolmogorov VS; Vaneev AN; Ivanenkov YA; Khudyakov AD; Kovalev SV; Erofeev AS; Gorelkin PV; Beloglazkina EK; Zyk NV; Khazanova ES; Majouga AG
Eur J Med Chem; 2022 Jan; 227():113936. PubMed ID: 34717125
[TBL] [Abstract][Full Text] [Related]
11. Development of small molecule-drug conjugates based on derivatives of natural proteasome inhibitors that exhibit selectivity for PSMA-expressing cancer cells.
Obara T; Kawano N; Tatsumi K; Katsuyama A; Nakajima K; Ogawa M; Ichikawa S
Bioorg Med Chem; 2024 Jun; 108():117773. PubMed ID: 38850999
[TBL] [Abstract][Full Text] [Related]
12. Engineering folate-drug conjugates to target cancer: from chemistry to clinic.
Vlahov IR; Leamon CP
Bioconjug Chem; 2012 Jul; 23(7):1357-69. PubMed ID: 22667324
[TBL] [Abstract][Full Text] [Related]
13. Chemotherapeutic drug delivery to cancer cells using a combination of folate targeting and tumor microenvironment-sensitive polypeptides.
Gao W; Xiang B; Meng TT; Liu F; Qi XR
Biomaterials; 2013 May; 34(16):4137-4149. PubMed ID: 23453200
[TBL] [Abstract][Full Text] [Related]
14. Design and synthesis of a folate-receptor targeted diazepine-ring-opened pyrrolobenzodiazepine prodrug conjugate.
Vlahov IR; Qi L; Santhapuram HKR; Felten A; Parham GL; Zou N; Wang K; You F; Vaughn JF; Hahn SJ; Klein HF; Kleindl PJ; Reddy J; Reno D; Nicoson J; Leamon CP
Bioorg Med Chem Lett; 2020 Apr; 30(7):126987. PubMed ID: 32029324
[TBL] [Abstract][Full Text] [Related]
15. Folate receptor-mediated celastrol and irinotecan combination delivery using liposomes for effective chemotherapy.
Soe ZC; Thapa RK; Ou W; Gautam M; Nguyen HT; Jin SG; Ku SK; Oh KT; Choi HG; Yong CS; Kim JO
Colloids Surf B Biointerfaces; 2018 Oct; 170():718-728. PubMed ID: 30005409
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and activity of a folate targeted monodisperse PEG camptothecin conjugate.
Henne WA; Kularatne SA; Hakenjos J; Carron JD; Henne KL
Bioorg Med Chem Lett; 2013 Nov; 23(21):5810-3. PubMed ID: 24064501
[TBL] [Abstract][Full Text] [Related]
17. Biological evaluation of mitochondria targeting small molecules as potent anticancer drugs.
Luo S; Dang X; Wang J; Yuan C; Hu Y; Lei S; Zhang Y; Lu D; Jiang F; Fu L
Bioorg Chem; 2021 Sep; 114():105055. PubMed ID: 34144278
[TBL] [Abstract][Full Text] [Related]
18. Neutrophil elastase as a versatile cleavage enzyme for activation of αvβ3 integrin-targeted small molecule drug conjugates with different payload classes in the tumor microenvironment.
Rebstock AS; Wiedmann M; Stelte-Ludwig B; Wong H; Johnson AJ; Izumi R; Hamdy A; Lerchen HG
Front Pharmacol; 2024; 15():1358393. PubMed ID: 38495100
[No Abstract] [Full Text] [Related]
19. An update on small molecules targeting CXCR4 as starting points for the development of anti-cancer therapeutics.
Grande F; Giancotti G; Ioele G; Occhiuzzi MA; Garofalo A
Eur J Med Chem; 2017 Oct; 139():519-530. PubMed ID: 28826086
[TBL] [Abstract][Full Text] [Related]
20. Pre-clinical studies of EC2629, a highly potent folate- receptor-targeted DNA crosslinking agent.
Reddy JA; Nelson M; Dircksen C; Vetzel M; Johnson T; Cross V; Westrick E; Qi L; Hahn S; Santhapuram HK; Parham G; Wang K; Vaughn JF; Felten A; Pugh M; Lu J; Klein P; Vlahov IR; Leamon CP
Sci Rep; 2020 Jul; 10(1):12772. PubMed ID: 32728172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]